Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.99 USD | -8.28% | -5.68% | +81.21% |
May. 09 | Generation Bio Co. Announces the Presentation of Preclinical Data on iqDNA and ctLNP Platforms At the ASGCT 27th Annual Meeting | CI |
Apr. 12 | Transcript : Generation Bio Co. - Special Call |
Financials (USD)
Sales 2024 * | 5.59M | Sales 2025 * | 4.77M | Capitalization | 199M |
---|---|---|---|---|---|
Net income 2024 * | -86M | Net income 2025 * | -97M | EV / Sales 2024 * | 8.02 x |
Net cash position 2024 * | 154M | Net cash position 2025 * | - | EV / Sales 2025 * | 41.7 x |
P/E ratio 2024 * |
-2.14
x | P/E ratio 2025 * |
-2.29
x | Employees | 174 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 85.43% |
Latest transcript on Generation Bio Co.
1 day | -8.28% | ||
1 week | -5.68% | ||
Current month | +5.65% | ||
1 month | -25.25% | ||
3 months | +48.76% | ||
6 months | +160.00% | ||
Current year | +81.21% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 53 | 17-09-30 | |
Matthew Norkunas
DFI | Director of Finance/CFO | 46 | 20-07-21 |
Antoinette Paone
COO | Chief Operating Officer | 46 | 18-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeff Jonas
BRD | Director/Board Member | 71 | 18-04-30 |
Director/Board Member | 76 | 17-11-30 | |
Jason Rhodes
FOU | Founder | 54 | 15-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 2.99 | -8.28% | 117,915 |
24-05-09 | 3.26 | +5.16% | 109,864 |
24-05-08 | 3.1 | -2.52% | 58,899 |
24-05-07 | 3.18 | -5.07% | 146,158 |
24-05-06 | 3.35 | +5.68% | 247,769 |
Delayed Quote Nasdaq, May 10, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+81.21% | 199M | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- GBIO Stock